Skip to content

The effect of fenugreek seeds on some gastrointestinal disorder in patients with mechanical ventilation.

The effect of fenugreek seeds on some gastrointestinal disorder in patients with mechanical ventilation

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2016021126511N1
Enrollment
Unknown
Registered
2016-05-06
Start date
2015-10-22
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Cerebrovascular diseases. Condition 2: Chronic lower respiratory diseases. Condition 3: Hypertensive diseases. Condition 4: Diseases of the nervous system. Condition 5: Ischaemic heart diseases. Condition 6: Diseases of the circulatory system. Condition 7: Diabetes Mellitus. Cerebral infarction, Occlusion and stenosis of precerebral arteries, not resulting in cerebral infarction , Other cerebrovascular diseases Chronic lower respiratory diseases Essential (primary) hypertension ,

Interventions

Intervention 1: in the intervention group will receive 3mg fenugreek seeds through NGT, twice a day, will be added to the special food for the feeding via NG tube for five days. Intervention 2: in Th
Treatment - Drugs
in the intervention group will receive 3mg fenugreek seeds through NGT, twice a day, will be added to the special food for the feeding via NG tube for five days.
in The control group was routinely given special food only / no action

Sponsors

Sabzevar University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
15 Years to 80 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: patients with informed consent to participate in research; mechanical ventilation; nasogastric tube feeding (NGT); age15-80 years old; hemodynamic stability; Absence of pancreatitis, severe renal failure; severe hypothyroidism; hyperparathyroidism diseases and pregnancy; Non is history partial or total gastrostomy and Food allergies. Exclusion criteria: Parents patient's or patient's refusal to continue participate in research; Patients who do not tolerate gavage; INR>2; patient died during the study.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Gastric residual volume. Timepoint: Every 3 hrs exactly before doing gavage. Method of measurement: by using 50cc gavage syringe.;The frequency of bowel movements. Timepoint: Every 24 hours. Method of measurement: Based on the registration number of daily excretion in patient chart.;Abdominal bloating and distension. Timepoint: Every 24 hours. Method of measurement: Measuring Abdominal circumference to Using a tape measure in centimeter and touching stiffness abdominal to hands and auscultation sounds with stethoscope.;Regurgitation. Timepoint: Every 24 hours. Method of measurement: Based on the regurgitation number of daily excretion in patient chart.;Abdominal sounds. Timepoint: Every 24 hours. Method of measurement: Listen to the sounds of each of the four quadrants of the abdomen with a stethoscope in 5 minutes once a day.;Gastrointestinal bleeding. Timepoint: Every 24 hours. Method of measurement: Sighting vomiting blood, disposal of light bleeding and similar to coffee grounds from the nasogastric tube , black and tarry stools , loss of hemoglobin 2 g over 48 hours without bloodshed another, guaiac test is positive. ( check hemoglobin routinely performed and recorded in the sector).

Countries

Iran (Islamic Republic of)

Contacts

Public ContactZarghi Azam

Sabzevar University of Medical Sciences

a.zarghi59@gmail.comebrazi.ali@chmail.irZarghiA92@Medsab.ac.ir+98 51 4466 0944

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026